BackgroundCheck.run
Search For

Lu Huang, 39Boston, MA

Related to:
Bo Xu 39 Xu Huang Sandy Xu 52 Xiaojie Tan 57 Yu Huang 35

Lu Huang Phones & Addresses

Allston, MA   

San Diego, CA   

Bloomington, IN   

New York, NY   

Work

Company: Bbb conglomerate group - New York, NY Jul 2012 Position: Corporate trainer

Education

School / High School: Shenyang Pharmaceutical University- Shenyang, CN 2008 Specialities: Bachelor in Undergraduate of International Economy and Trade

Skills

Quantitative Analytics • Marketing Research • Social Media Marketing • Data Analysis • SAS • Excel • Integrated Marketing • Marketing Research • Presentation • Mandarin Chinese • Leadership

Ranks

Licence: New York - Currently registered Date: 2010
Get Report
Control this profile

Mentions for Lu Huang

Career records & work history

Lawyers & Attorneys

Lu Huang Photo 1

Lu Huang - Lawyer

Address:
Junhe Law Offices
Licenses:
New York - Currently registered 2010
Education:
George Washington University Law School

Lu Huang resumes & CV records

Resumes

Lu Huang Photo 42

Lu Huang - New York, NY

Work:
BBB Conglomerate Group - New York, NY Jul 2012 to Sep 2012
Corporate Trainer San Diego Asian Film Foundation - San Diego, CA Mar 2012 to Jul 2012
Operations/Marketing Associate, Intern, Liaoning TV - Shenyang,China Aug 2011 to Dec 2011
Research Assistant
Education:
Shenyang Pharmaceutical University - Shenyang, CN 2008 to 2012
Bachelor in Undergraduate of International Economy and Trade Alliant International University - San Diego, CA 2011
Bachelor in Integrated Marketing Communications
Skills:
Quantitative Analytics, Marketing Research, Social Media Marketing, Data Analysis, SAS, Excel, Integrated Marketing, Marketing Research, Presentation, Mandarin Chinese,Leadership

Publications & IP owners

Us Patents

Methods Of Making Chimeric Antigen Receptor-Expressing Cells

US Patent:
2022036, Nov 17, 2022
Filed:
Aug 30, 2019
Appl. No.:
17/271430
Inventors:
- Basel, CH
Michael R. Greene - Groton MA, US
Jennifer Brogdon - Sudbury MA, US
Boris Engels - Arlington MA, US
Glenn Dranoff - Sudbury MA, US
Olja Kodrasi - Quincy MA, US
Hyungwook Lim - Cambridge MA, US
Akash Sohoni - Cambridge MA, US
Elizabeth Dorothy Pratico - East Boston MA, US
Anniesha Hack - East Hanover NJ, US
Aida Abujoub - Winchester MA, US
Tony Fleming - Stow MA, US
Lu Huang - West Roxbury MA, US
Connie Hong - Somerville MA, US
John Blankenship - Acton MA, US
Brian Holmberg - Somerville MA, US
Chonghui Zhang - Cambridge MA, US
Dexiu Bu - Melrose MA, US
Andrew Price - Cambridge MA, US
Xu Zhu - Cambridge MA, US
Andrew Stein - Cambridge MA, US
Attilio Bondanza - Basel, CH
International Classification:
C12N 5/0783
A61K 35/17
A61K 31/519
A61K 38/20
C07K 16/28
C07K 14/705
Abstract:
The invention provides methods of making immune effector cells (for example, T cells, NK cells) that express a chimeric antigen receptor (CAR), and compositions generated by such methods.

Dosing Regimen And Combination Therapies For Multispecific Antibodies Targeting B-Cell Maturation Antigen

US Patent:
2022033, Oct 20, 2022
Filed:
Jun 22, 2020
Appl. No.:
17/620987
Inventors:
- Basel, CH
Aida ABUJOUB - Winchester MA, US
John BLANKENSHIP - Acton MA, US
Anuradha CONNOR - Cambridge MA, US
Mirek DOSTALEK - Binningen, CH
Tony FLEMING - Stow MA, US
Brian HOLMBERG - Somerville MA, US
Connie HONG - Somerville MA, US
Lu HUANG - West Roxbury MA, US
Haihui LU - Winchester MA, US
K. Gary J. VANASSE - Wellesley MA, US
International Classification:
C07K 16/28
A61P 35/00
A61K 9/00
A61K 31/167
A61K 31/417
A61K 31/56
Abstract:
The present disclosure relates to dosing regimens, formulations, and combinations comprising a multispecific antibody having at least binding specificity towards B cell maturation antigen (BCMA) and a T-cell engaging arm; and methods of using such multispecific antibodies in the treatment or prevention of disease, such as, cancer.

Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (Car)- Expressing Cell

US Patent:
2022019, Jun 23, 2022
Filed:
Sep 1, 2021
Appl. No.:
17/464528
Inventors:
- Basel, CH
- Philadelphia PA, US
Barbara Brannetti - Cambridge MA, US
Jennifer Brogdon - Sudbury MA, US
Naveen Kumar Dakappagari - Carlsbad CA, US
Saar Gill - Philadelphia PA, US
Steven Highfill - Bethesda MD, US
Lu Huang - West Roxbury MA, US
Carl H. June - Merion Station PA, US
Ju Young Kim - Carlsbad CA, US
Ming Lei - Acton MA, US
Na Li - Cambridge MA, US
Andreas Loew - Boston MA, US
Elena Orlando - Somerville MA, US
Marco Ruella - Ardmore PA, US
Thai Tran - Carlsbad CA, US
Jimin Zhang - Chestnut Hill MA, US
Li Zhou - Cambridge MA, US
International Classification:
C07K 14/705
C07K 14/725
C07K 16/28
A61K 45/06
A61K 39/00
Abstract:
The invention provides compositions and methods for treating diseases associated with expression of CD19, e.g., by administering a recombinant T cell comprising the CD19 CAR as described herein, in combination with one or more B-cell inhibitors, e.g., inhibitors of one or more of CD10, CD20, CD22, CD34, CD123, FLT-3, ROR1, CD79b, CD179b, or CD79a. The disclosure additionally features novel antigen binding domains and CAR molecules directed to CD20 and CD22, and uses, e.g., as monotherapies or in combination therapies. The invention also provides kits and compositions described herein.

Chimeric Antigen Receptors And Uses Thereof

US Patent:
2021022, Jul 22, 2021
Filed:
Nov 25, 2020
Appl. No.:
17/104983
Inventors:
Michael R. Greene - Cambridge MA, US
- Basel, CH
Attilio Bondanza - Basel, CH
Jennifer Brogdon - Sudbury MA, US
Dexiu Bu - Melrose MA, US
Serena De Vita - Brookline MA, US
Glenn Dranoff - Sudbury MA, US
Boris Engels - Arlington MA, US
Tony Fleming - Stow MA, US
Brian Walter Granda - Salisbury MA, US
Michael R. Greene - Groton MA, US
Carla Patricia Guimaraes - Boston MA, US
Anniesha Hack - East Hanover MA, US
Brian Holmberg - Somerville MA, US
Connie Hong - Somerville MA, US
Lu Huang - West Roxbury MA, US
Olja Kodrasi - Quincy MA, US
Joni Waiee Lam - Somerville MA, US
Hyungwook Lim - Cambridge MA, US
Elizabeth Dorothy Pratico - East Boston MA, US
Andrew Price - Cambridge MA, US
Akash Sohoni - Cambridge MA, US
Andrew Marc Stein - Cambridge MA, US
Louise Treanor - Cambridge MA, US
Chonghui Zhang - Cambridge MA, US
Xu Zhu - Cambridge MA, US
International Classification:
A61K 35/17
C07K 16/28
A61P 35/00
A61K 45/06
A61K 39/395
C07K 14/705
A61K 38/17
C12N 5/0783
C07K 14/725
Abstract:
The invention provides immune effector cells (for example, T cells, NK cells) that express a chimeric antigen receptor (CAR), and compositions and methods thereof.

Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Comprising A Cd20 Binding Domain

US Patent:
2020011, Apr 16, 2020
Filed:
Oct 25, 2019
Appl. No.:
16/664223
Inventors:
- Basel, CH
- Philadelphia PA, US
Boris Engels - Arlington MA, US
Brian Granda - Salisbury MA, US
Lu Huang - West Roxbury MA, US
Ming Lei - Acton MA, US
Na Li - Cambridge MA, US
Jimin Zhang - Chestnut Hill MA, US
Carla Guimaraes - Boston MA, US
International Classification:
A61K 35/17
A61K 38/17
C12N 15/85
C07K 16/28
A61P 35/00
Abstract:
The invention provides compositions and methods for treating diseases associated with expression of CD20 or CD22. The invention also relates to chimeric antigen receptor (CAR) specific to CD20 or CD22, vectors encoding the same, and recombinant T or natural killer (NK) cells comprising the CD20 CAR or CD22 CAR. The invention also includes methods of administering a genetically modified T cell or NK cell expressing a CAR that comprises a CD20 or CD22 binding domain.

Bcma Chimeric Antigen Receptors And Uses Thereof

US Patent:
2019038, Dec 19, 2019
Filed:
Jun 12, 2019
Appl. No.:
16/439495
Inventors:
- Basel, CH
John Blankenship - Acton MA, US
Dexiu Bu - Melrose MA, US
Tony Fleming - Stow MA, US
Brian Holmberg - Somerville MA, US
Connie Hong - Somerville MA, US
Lu Huang - West Roxbury MA, US
Chonghui Zhang - Cambridge MA, US
International Classification:
C07K 16/28
C07K 14/725
C07K 14/705
C12N 5/0783
A61P 35/00
A61K 35/17
Abstract:
The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to chimeric antigen receptor (CAR) specific to BCMA, vectors encoding the same, and recombinant T cells comprising the BCMA CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a BCMA binding domain.

Binding Molecules Against Bcma And Uses Thereof

US Patent:
2019036, Dec 5, 2019
Filed:
May 30, 2019
Appl. No.:
16/426914
Inventors:
- Basel, CH
John BLANKENSHIP - Acton MA, US
Tony FLEMING - Stow MA, US
Brian HOLMBERG - Somerville MA, US
Connie HONG - Somerville MA, US
Lu HUANG - Cambridge MA, US
Haihui LU - Cambridge MA, US
International Classification:
C07K 16/28
C07K 16/46
A61K 47/68
A61P 35/00
Abstract:
The present disclosure provides BCMA binding molecules that specifically bind to human BCMA, conjugates comprising the BCMA binding molecules, and pharmaceutical compositions comprising the BCMA binding molecules and the conjugates. The disclosure further provides methods of using the BCMA binding molecules to treat cancers that express cell surface BCMA. The disclosure yet further provides recombinant host cells engineered to express the BCMA binding molecules and methods of producing the BCMA binding molecules by culturing the host cells under conditions in which the BCMA binding molecules are expressed.

Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (Car)- Expressing Cell

US Patent:
2019029, Sep 26, 2019
Filed:
Jan 24, 2019
Appl. No.:
16/256731
Inventors:
- Basel, CH
- Philadelphia PA, US
Barbara Brannetti - Cambridge MA, US
Jennifer Brogdon - Sudbury MA, US
Naveen Kumar Dakappagari - Carlsbad CA, US
Saar Gill - Philadelphia PA, US
Steven Highfill - Bethesda MD, US
Lu Huang - Cambridge MA, US
Carl H. June - Merion Station PA, US
Ju Young Kim - Carlsbad CA, US
Ming Lei - Acton MA, US
Na Li - Cambridge MA, US
Andreas Loew - Boston MA, US
Elena Orlando - Somerville MA, US
Marco Ruella - Ardmore PA, US
Thai Tran - Carlsbad CA, US
Jimin Zhang - Chestnut Hill MA, US
Li Zhou - Cambridge MA, US
International Classification:
C07K 14/705
A61K 39/00
C07K 16/28
C07K 14/725
A61K 45/06
Abstract:
The invention provides compositions and methods for treating diseases associated with expression of CD19, e.g., by administering a recombinant T cell comprising the CD19 CAR as described herein, in combination with one or more B-cell inhibitors, e.g., inhibitors of one or more of CD10, CD20, CD22, CD34, CD123, FLT-3, ROR1, CD79b, CD179b, or CD79a. The disclosure additionally features novel antigen binding domains and CAR molecules directed to CD20 and CD22, and uses, e.g., as monotherapies or in combination therapies. The invention also provides kits and compositions described herein.

Possible Relatives

Cynthia M Huang  David T Huang  Dawei Huang  Dayong Huang  Da Huang  Daijie D Huang  Daisy Huang  Lu Meng  Lu Li  Lu Liu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.